Mesoblast Limited - MESO

SEC FilingsOur MESO Tweets

About Gravity Analytica

Recent News

  • 06.12.2025 - Mesoblast Maintains Momentum with FDA
  • 06.05.2025 - Becoming a substantial holder
  • 06.04.2025 - Becoming a substantial holder
  • 06.03.2025 - Becoming a substantial holder
  • 06.02.2025 - Ceasing to be a substantial holder
  • 05.15.2025 - FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
  • 05.13.2025 - Becoming a substantial holder
  • 05.08.2025 - Ceasing to be a substantial holder
  • 05.07.2025 - Becoming a substantial holder
  • 05.07.2025 - Ceasing to be a substantial holder

Recent Filings

  • 05.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 05.15.2025 - EX-99.1 EX-99.1
  • 04.30.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 04.30.2025 - EX-99.1 EX-99.1
  • 04.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 04.29.2025 - EX-99.1 EX-99.1